Voluntary muscle is the largest human organ system. The musculotendinous contractual unit sustains posture against gravity and movement against inertia. However, when exposed to single or recurrent episodes of biomechanical overloading, muscle injury may occur. Although chronic muscular injuries and myofascial pain syndromes are commonly diagnosed, they remain poorly understood.
Techniques for evaluation of the muscular components of a pain syndrome involve palpation, strength testing, range of motion, and assessment of muscle endplay. Management of acute injuries may necessitate imaging and surgery consultation for lacerations or hemorrhage. Treatment of acute syndromes consists of cryotherapy and reduced activity, whereas chronic syndromes may require multiple therapeutic approaches, applied together or sequentially.
KeywordsFibromyalgia Botulinum Toxin Trigger Point Muscle Spasm Myofascial Pain
Unable to display preview. Download preview PDF.
References and Recommended Reading
- 1.Simons DG, Travell JG, Simons LS: The Trigger Point Manual, vol 1, edn 2. Baltimore, MD: Williams & Wilkins; 1999. Most recent addition of a classic medical textbook that should be read and studied by physicians who treat muscular pain. Empiric and scientific evidence that support Travell and Simon’s concepts of character and causality of muscle pain is biased, but clinical observations and illustrations make this book a necessary clinical tool.Google Scholar
- 5.Drewes AM, Jennum P: Epidemiology of myofascial pain, low back pain, morning stiffness and sleep-related complaints in the general population [abstract]. J Musculoskeletal Pain 1995, 3(suppl 1):68.Google Scholar
- 9.Gerwin RD: A study of 96 subjects examined both for fibromyalgia and myofascial pain [abstract]. J Musculoskeletal Pain 1995, 3(suppl 1):121.Google Scholar
- 10.Frolich D, Frolich R: Das Piriformissyndrom: eine haufige differential-diagnose des lumbglutaalen Schmerzes (Piriformis syndrome: a frequent item in the differential diagnosis of lumbogluteal pain). Manuelle Medizin 1995, 33:7–10.Google Scholar
- 14.Fields HL: Pain. New York, NY: McGraw-Hill; 1987.Google Scholar
- 15.Layzer RB: Muscle pains and cramps. In Neurology in Clinical Practice. Edited by Bradley WG et al. Boston, MA: Butterworth-Hennepann; 1991:363–368.Google Scholar
- 22.Simons DG: Clinical and etiological update of myofascial pain from trigger points. In Clinical Overview and Pathogenesis of Fibromyalgia Syndrome, Myofascial Pain Syndrome, and Other Pain Syndromes. Binghamton, NY: Hayworth Medical Press; 1996:93–122.Google Scholar
- 23.Garvey TA, Marks MR, Wiesel SW: A prospective, randomized, double-blind evaluation trigger point injections therapy for low back pain. Spine 1989, 14:962–964. Benchmark, well-done study that demonstrates efficacy of dry needling compared with injections of active substances into TrPs.PubMedCrossRefGoogle Scholar
- 24.Cyriax J: Textbook of Orthopaedic Medicine: Diagnosis of Soft Tissue Lesions, edn 8. Baltimore, MD: Williams & Wilkins; 1984.Google Scholar
- 29.Boyles WF, Glassman JM, Soyka JP: Management of acute musculoskeletal conditions: thoracolumbar strain or sprain. A double-blind evaluation comparing the efficacy and safety of carisporodol with diazepam. Todays Ther Trends 1983, 1:1.Google Scholar
- 30.Gold RH: Orphenadrine citrate: sedative or muscle relaxant? Clin Ther 1978, 1:451–453.Google Scholar
- 34.O’Brien CF: Clinical applications of botulinum toxin: implications for pain management. Pain Digest 1998, 8:342–345.Google Scholar
- 36.Yue SK: Initial experience in the use of botulinum toxin A for the treatment of myofascial related muscle dysfunction. J Musculoskeletal Pain 1995, 3(suppl 1):22.Google Scholar